Fibrosing colonopathy: Difference between revisions

(Created page with "==Background== *Disease that occurs in patients with cystic fibrosis treated with enteric coated pancreatic enzymes, particularly with high doses<ref>Fitzsimmons SC, Burkh...")
 
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
==Background==
==Background==
[[File:Diameters of the large intestine.png|thumb|Average inner diameters and ranges of different sections of the large intestine.<ref> Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, et al. (July 2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". Journal of Visualized Experiments (41). doi:10.3791/1931. PMC 3149991. PMID 20689513.</ref>]]
*Disease that occurs in patients with [[cystic fibrosis]] treated with enteric coated pancreatic enzymes, particularly with high doses<ref>Fitzsimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336(18):1283-9.</ref>
*Disease that occurs in patients with [[cystic fibrosis]] treated with enteric coated pancreatic enzymes, particularly with high doses<ref>Fitzsimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336(18):1283-9.</ref>
*More common in children, but reported in adults
*More common in children, but reported in adults
Line 22: Line 23:
==Management<ref>https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy</ref>==
==Management<ref>https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy</ref>==
*Anti-inflammatory therapy (e.g. [[prednisone]] pulses)
*Anti-inflammatory therapy (e.g. [[prednisone]] pulses)
*Definitive treatment is balloon dilation or surgical resection of structured portion of colon


==Disposition==
==Disposition==

Latest revision as of 21:01, 24 September 2025

Background

Average inner diameters and ranges of different sections of the large intestine.[1]
  • Disease that occurs in patients with cystic fibrosis treated with enteric coated pancreatic enzymes, particularly with high doses[2]
  • More common in children, but reported in adults
  • Characterized by progressive submucosal fibrosis, particularly of the proximal colon

Clinical Features

Differential Diagnosis

Pediatric Abdominal Pain

0–3 Months Old

3 mo–3 y old

3 y old–adolescence


Evaluation

  • Evaluate for alternative diagnoses
  • Imaging may show[4]:
    • long or short segment colon stricture, typically right-sided
    • +/- affected colon shortened/retracted
    • thickening of bowel wall on US prior to stricture formation[5]

Management[6]

  • Anti-inflammatory therapy (e.g. prednisone pulses)
  • Definitive treatment is balloon dilation or surgical resection of structured portion of colon

Disposition

See Also

External Links

References

  1. Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, et al. (July 2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". Journal of Visualized Experiments (41). doi:10.3791/1931. PMC 3149991. PMID 20689513.
  2. Fitzsimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336(18):1283-9.
  3. Rosenstein BJ, Langbaum TS (May 1983). "Incidence of distal intestinal obstruction syndrome in cystic fibrosis". Journal of Pediatric Gastroenterology and Nutrition. 2 (2): 299–301
  4. https://radiopaedia.org/articles/fibrosing-colonopathy-1?lang=us
  5. https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy
  6. https://www.sciencedirect.com/topics/neuroscience/fibrosing-colonopathy